This announcement is a separate document:
シンバイオ製薬：B細胞リンパ腫に対するブリンシドフォビルの抗腫瘍効果 AACR Annual Meeting 2024における研究成果の学会発表
SymBio Pharmaceuticals: Antitumor effects of brincidofovir on B-cell lymphoma: conference presentation of research results at AACR Annual Meeting 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.